Retinoic acid treated P19 embryonal carcinoma cells differentiate into oligodendrocytes capable of myelination
- 1 April 1996
- journal article
- Published by Elsevier in Neuroscience
- Vol. 71 (3) , 845-853
- https://doi.org/10.1016/0306-4522(95)00494-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Proliferation of oligodendrocyte precursor cells depends on electrical activity in axonsNature, 1993
- Carbonic anhydrase in distinct precursors of astrocytes and oligodendrocytes in the forebrains of neonatal and young ratsDevelopmental Brain Research, 1992
- Neural differentiation-associated generation of microglia-like phagocytes in murine embryonal carcinoma cell lineDevelopmental Brain Research, 1991
- Cell density and cell cycle effects on retinoic acid-induced embryonal carcinoma cell differentiationDevelopmental Biology, 1990
- Immunocytochemical localization by electron microscopy of 2'3'-cyclic nucleotide 3'-phosphodiesterase in developing oligodendrocytes of normal and mutant brainJournal of Neuroscience, 1988
- Induced muscle differentiation in an embryonal carcinoma cell line.Molecular and Cellular Biology, 1983
- The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell lineDevelopmental Biology, 1983
- Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells.The Journal of cell biology, 1982
- Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell lineCell, 1979
- A skeletal muscle cell line isolated from a mouse teratocarcinoma undergoes apparently normal terminal differentiation in vitro*1Experimental Cell Research, 1978